| Net Cash Provided by (Used in) Financing Activities |
$4,010 |
USD |
5.5% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$1,006,311 |
USD |
-57403% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
32,700,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$4,168,293 |
USD |
-1964% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$149,388 |
USD |
-83% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,838 |
USD |
275% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$2,075,996 |
USD |
293% |
Q3 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$7,788,297 |
USD |
-462% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$282,411 |
USD |
-13% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$103,840 |
USD |
0% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |